These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6815740)

  • 1. Serum binding of tocainide and its enantiomers in human subjects.
    Sedman AJ; Bloedow DC; Gal J
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):165-8. PubMed ID: 6815740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific salivary excretion of tocainide enantiomers in man.
    Pillai GK; Axelson JE; Kerr CR; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):209-21. PubMed ID: 6424192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective serum protein binding of mexiletine enantiomers in man.
    McErlane KM; Igwemezie L; Kerr CR
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):141-4. PubMed ID: 3589151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of (R,S)-tocainide. Some stereoselective aspects.
    Gal J; French TA; Zysset T; Haroldsen PE
    Drug Metab Dispos; 1982; 10(4):399-404. PubMed ID: 6126341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of ketoprofen enantiomers in man: method development and its application.
    Hayball PJ; Nation RL; Bochner F; Newton JL; Massy-Westropp RA; Hamon DP
    Chirality; 1991; 3(6):460-6. PubMed ID: 1812956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific high-performance liquid chromatographic determination of tocainide.
    Carr RA; Foster RT; Freitag D; Pasutto FM
    J Chromatogr; 1991 May; 566(1):155-62. PubMed ID: 1909341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
    Knadler MP; Brater DC; Hall SD
    J Pharmacol Exp Ther; 1989 May; 249(2):378-85. PubMed ID: 2724130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas--liquid chromatographic resolution and assay of tocainide enantiomers using a chiral capillary column and study of their selective disposition in man.
    McErlane KM; Pillai GK
    J Chromatogr; 1983 May; 274():129-38. PubMed ID: 6409913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK; Caldwell J
    Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of the enantiomers of tocainide in blood plasma using gas-liquid chromatography with electron-capture detection.
    Sedman AJ; Gal J
    J Chromatogr; 1984 Mar; 306():155-64. PubMed ID: 6425350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal intoxication by tocainide.
    Sperry K; Wohlenberg N; Standefer JC
    J Forensic Sci; 1987 Sep; 32(5):1440-6. PubMed ID: 3117960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias.
    Thomson AH; Murdoch G; Pottage A; Kelman AW; Whiting B; Hillis WS
    Br J Clin Pharmacol; 1986 Feb; 21(2):149-54. PubMed ID: 3082345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of S- and R-tocainide in human plasma after heptafluorobutyrylation, separation on Chirasil-Val and electron-capture detection.
    Antonsson AM; Gyllenhaal O; Kylberg-Hanssen K; Johansson L; Vessman J
    J Chromatogr; 1984 Jun; 308():181-7. PubMed ID: 6430940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific interaction of tocainide with the cardiac sodium channel.
    Sheldon RS; Cannon NJ; Nies AS; Duff HJ
    Mol Pharmacol; 1988 Mar; 33(3):327-31. PubMed ID: 2451117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro.
    Block AJ; Merrill D; Smith ER
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):216-21. PubMed ID: 2452317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects.
    McErlane KM; Axelson J; Vaughan R; Kerr CR; Price JD; Igwemezie L; Pillai G
    Eur J Clin Pharmacol; 1990; 39(4):373-6. PubMed ID: 2127569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective gallopamil protein binding.
    Gross AS; Eser C; Mikus G; Eichelbaum M
    Chirality; 1993; 5(6):414-8. PubMed ID: 8398599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of tocainide in serum by capillary gas chromatography.
    Smith PJ
    Ther Drug Monit; 1986; 8(3):361-4. PubMed ID: 3092408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.